ASIC has released a draft regulatory guide alongside a consultation paper intended to help providers of Buy Now Pay Later services understand the modified responsible lending obligations and requirements.
On 10 March 2025, the Health Sciences Authority launched its public consultation for the draft on the Best Practices Guide for Medical Device Cybersecurity. The document provides medical device manufacturers and healthcare providers with best practice recommendations and considerations on general cybersecurity principles to protect the security of medical devices for their entire product life cycle.
On 7 March 2025, the Ministry of Health announced a host of changes to the healthcare system to address the shifting needs of the Singapore population. These changes included a review of advertising regulations for certain healthcare professionals, the recognition of family medicine as a medical specialty and the introduction of registration requirements for psychologists.
The Agreement on Conformity Assessment and Acceptance of Industrial Products (ACAA) is an intermediary step for Ukraine to benefit from the mutual recognition of product quality between the EU and Ukraine until our country becomes a full EU Member State. The ACAA covers 27 groups of industrial goods/technical regulations. Ukraine’s ACAA implementation plan was sequenced in priority sectors to allow a step-by-step sectoral implementation of the ACAA.
On 13 December 2024, the new “Regulation (EU) 2023/988 of the European Parliament and of the Council of 10 May 2023 on General Product Safety” (“GPSR”) came into force.
The GPSR repeals the General Product Safety Directive (2001) and introduces an updated regime to ensure product safety in light of evolving technologies and means of trade. As a regulation, the GPSR is directly applicable to all EU member states without the need for national transpositions.
On 1 October 2024, the UAE Government has issued a new Federal Decree-Law No. 38 of 2024 to regulate medical products, the pharmacy profession and pharmaceutical establishments (the “Law”).
The Law replaces Federal Law No. (8) of 2019 on Medical Products, Pharmacy Profession and Pharmaceutical Establishments including its later amendments. However, its implementing regulations remain in effect to the extent they do not contradict with the Law.
On 5 December 2024, the Health Sciences Authority of Singapore published an update regarding products found by foreign regulators in November 2024 to contain impermissible and potent ingredients that may cause harmful side effects.
The Health Sciences Authority (HSA) conducted a large-scale operation in collaboration with major e-commerce and social media platforms, removing over 3,300 listings of illegal health products. The operation highlights the HSA’s commitment to consumer safety, targeting substandard or counterfeit products that are potentially unsafe and pose health risks.
The European Accessibility Act is a directive aimed at improving the accessibility of products and services for people with disabilities across the European Union. It establishes common accessibility requirements for a wide range of products and services provided to consumers to ensure that people with disabilities have better access to digital and physical environments, thereby promoting their inclusion and participation in society.
The proposed amendments to the Consumer Protection Act Regulations in South Africa aim to enhance consumer privacy by regulating direct marketing practices. Open for public comment until 15 January 2025, these changes focus on creating an opt-out registry managed by the National Consumer Commission, allowing consumers to block unsolicited electronic communications. Direct marketers will be required to register, renew annually, and cleanse their databases regularly to comply with the new rules. The amendments also introduce enforcement mechanisms for non-compliance and align with the Protection of Personal Information Act, ensuring comprehensive consumer protection against unwanted marketing.